NANKAI CHEMICAL COMPANY LIMITED

NANKAI CHEMICAL COMPANY LIMITED

TTSE:4040
4,355.00
JPY
-135.00
(-3.01%)
6.28BMarket Cap
Nov 13Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
8,728.84
13,556.27
15,241.28
10,121.4
10,409.89
10,433.54
- -
Basic EPS, GAAP
82.18
359.24
391.9
586.41
505.55
1,375.09
- -
Free Cash Flow per Basic Share
-170.2
297.81
101.86
288.65
-927.43
-759.37
- -
Dividend per Share
7.95
14.77
14.77
24.31
59.27
64.89
- -
Book Value per Share
2,117.13
2,451.16
2,592.07
3,714.65
4,172.91
5,541.83
- -
Tangible Book Value per Share
2,021.16
2,347.77
2,298.12
3,401.88
3,888.19
5,281.54
- -
Basic Weighted Avg Shares
2
1
1
2
2
2
2
Sales/Revenue/Turnover
16,463
17,434
19,601
19,987
20,900
21,063
- -
Operating Margin (%)
4.44
3.6
4.06
7.83
6.25
8.07
- -
Depreciation Expense
955
975
1,005
1,022
1,136
1,217
- -
Net Income, GAAP
155
462
504
1,158
1,015
2,776
- -
Effective Tax Rate (%)
- -
- -
23.08
29.12
21.97
31.4
- -
Profit Margin (%)
0.94
2.65
2.57
5.79
4.86
13.18
- -
Working Capital
587
296
901
1,106
-332
4,846
- -
LT Debt
3,929
3,496
3,378
2,875
3,606
2,664
- -
Total Equity
4,034
4,674
5,190
7,500
8,502
11,171
- -
Return on Invested Capital (%)
- -
- -
5.19
9.07
7.44
7.94
- -
Return on Capital (%)
- -
- -
4.54
9.76
7.68
19.26
- -
Return on Common Equity (%)
- -
10.72
10.33
18.45
12.83
28.55
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
1,692
1,013
- -
LT Borrowings
2,879
2,452
- -
LT Finance Leases
- -
212
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
5,618
6,281
6,964

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
9,041
9,812
- -
Cash, Cash Equivalents & STI
1,628
2,040
- -
Accounts Receivable, Net
3,499
4,311
- -
Inventories
3,218
2,690
- -
Total Current Liabilities
10,382
4,966
- -
Payables & Accruals
- -
- -
- -
ST Debt
1,692
1,013
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
23.23%
31.39%
Free Cash Flow
- -
-78.87%
-17.67%
Net Income, GAAP
- -
99.61%
173.5%
Sales/Revenue/Turnover
- -
5.13%
0.78%
Total Cash Common Dividend
- -
- -
10.08%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
20,900
2026
- -
- -
- -
- -
21,063
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
505.55
2026
- -
- -
- -
- -
1,375.09
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
59.27
2026
- -
- -
- -
- -
64.89
2027
- -
- -
- -
- -
- -

Company Description

CEO
Shinya Sugioka
Full Time Employees
319
Sector
Process industries
Industry
Chemicals: specialty
Address
Yotsubashi Star Building Osaka OS Japan 550-0015
IPO Date
Apr 20, 2023
Business
Nankai Chemical Company, Limited (4040.T) manufactures and sells chemical products primarily for the food, pharmaceutical, and industrial sectors. The company produces diphenhydramine hydrochloride, an antihistamine used in pharmaceuticals; carrageenan and other seaweed extracts for food stabilizers and gelling agents; food additives such as sodium hyaluronate and konjac flour; industrial chemicals including synthetic resins and coating materials; and pharmaceutical intermediates like ephedrine hydrochloride. It offers these products through domestic sales in Japan and exports to international markets in Asia and Europe. Founded in 1948 and headquartered in Tokyo, Japan, Nankai Chemical operates production facilities in Osaka and other regions across Japan, serving customers in the food processing, cosmetics, and healthcare industries. In recent years, the company has focused on expanding its production capacity for high-purity carrageenan products and strengthening supply chain partnerships with global seaweed suppliers to meet rising demand for natural food ingredients.